Ancient Art’s Medicines Co MDCO Stock Holding History

Ancient Art’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-27,520	Closed	-$769K	–	17
2019 Q1	$769K	Buy	+27,520	New	+$649K	0.14%	14

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Ancient Art's MDCO Position: Q2 2019 in Review

Ancient Art sold out of Medicines Co (MDCO) in Q2 2019, closing a stake of 27,520 shares — an estimated $769K sold.

Ancient Art first reported a position in MDCO in Q1 2019 and held it in 1 quarter. The position peaked at $769K in Q1 2019. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

Ancient Art reported no remaining Medicines Co position as of Q2 2019 after selling out during the quarter.
Ancient Art sold 27,520 Medicines Co shares in Q2 2019, an estimated $769K.
Ancient Art first reported a position in Medicines Co in Q1 2019 and held it in 1 quarter.
Ancient Art's Medicines Co position peaked at $769K in Q1 2019.
228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on Ancient Art's 13F filing for Q2 2019, filed 14 Aug 2019.